StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Equity Method Income by Quarter

Equity Method Income ($M)

QuarterlyAnnual

Novartis Equity Method Income: -$3M in Q3 2026, down 25.0% from a year earlier.

Latest, Q3 2026
-3
Period ended Sep 30, 2026
Change on a year earlier
-25.0%
-4 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
30
Documents cited below

Where the Q3 2026 figure comes from

“|| Loss from associated companies | – 3 | – 4”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEquity Method Income ($M)Year on yearSource
Q3 2026Sep 30, 2026-3-25.0%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026-2-33.3%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 2026-30.0%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-2-33.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-40.0%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025-3+50.0%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 2025-3-89.7%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 2024-3-50.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024-4+33.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 2024-20.0%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 2024-29+1,350.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023-6+100.0%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 2023-3-40.0%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023-2-166.7%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 2023-20.0%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022-3-100.0%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Equity Method Income ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-assoc

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.